Company Profiles

driven by the PitchBook Platform

Edimer Pharmaceuticals

Description

Developer of drugs for the treatment of X-linked hypohidrodic ectodermal dysplasia (XLHED). The company's product treats a rare genetic condition that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems and hair and tooth malformations.

2009

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$18M

Latest Deal Amount

$40M

Total Amount Raised

Description

Developer of drugs for the treatment of X-linked hypohidrodic ectodermal dysplasia (XLHED). The company's product treats a rare genetic condition that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems and hair and tooth malformations.

Website:

www.edimerpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

55 Cambridge Parkway Suite 102W Cambridge, MA 02142United States +1 (617) 758-4300
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Edimer Pharmaceuticals's full profile, request a free trial.

Edimer Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Edimer Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Edimer Pharmaceuticals Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
New Enterprise AssociatesVenture CapitalMinority000 0000000 0000
Sanofi-Genzyme BioventuresCorporate Venture CapitalMinority000 0000000 0000
Third Rock VenturesVenture CapitalMinority000 0000000 0000
VI PartnersVenture CapitalMinority000 0000000 0000
New Enterprise Associates Venture Capital
Sanofi-Genzyme Bioventures Corporate Venture Capital
Third Rock Ventures Venture Capital
VI Partners Venture Capital

Edimer Pharmaceuticals Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Neil Kirby Ph.DChief Executive Officer, President & Board Member
Ramsey JohnsonSenior Director, Clinical and Regulatory Operations
Neil Kirby Ph.D Chief Executive Officer, President & Board Member
Ramsey Johnson Senior Director, Clinical and Regulatory Operations

Edimer Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Bill AliskiSelfBoard Member000 0000
Cary Pfeffer MDThird Rock VenturesPartner000 0000
Daniel LynchThird Rock VenturesVenture Partner000 0000
David MottNew Enterprise AssociatesGeneral Partner000 0000
Philip Reilly MDThird Rock VenturesVenture Partner000 0000
Bill Aliski Board Member Self
Cary Pfeffer MD Partner Third Rock Ventures
Daniel Lynch Venture Partner Third Rock Ventures
David Mott General Partner New Enterprise Associates
Philip Reilly MD Venture Partner Third Rock Ventures
Request full access to PitchBook